Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 12:31 PM ET

Date/Time Source News Release
05/28/2025 08:00 AM EDT GlobeNewswire Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
05/13/2025 04:05 PM EDT GlobeNewswire Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
05/07/2025 08:00 AM EDT GlobeNewswire Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
04/30/2025 08:00 AM EDT GlobeNewswire Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
04/07/2025 08:00 AM EDT GlobeNewswire Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025
04/02/2025 04:05 PM EDT GlobeNewswire Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
03/31/2025 08:00 AM EDT GlobeNewswire Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
03/26/2025 07:00 AM EDT GlobeNewswire Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
03/11/2025 04:05 PM EDT GlobeNewswire Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
03/03/2025 07:00 AM EST GlobeNewswire Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025
Page

Additional News

As of June 12, 2025 • 12:31 PM ET

Date/Time Source News Release
05/13/2025 06:34 PM EDT SeekingAlpha Verrica signals sustainable growth trajectory as YCANTH revenues surpass $3M and Phase 3 milestone looms
05/13/2025 06:33 PM EDT SeekingAlpha Verrica Pharmaceuticals, Inc. (VRCA) Q1 2025 Corporate Update Conference Call
05/13/2025 05:25 PM EDT Zacks Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
05/13/2025 05:03 PM EDT SeekingAlpha Verrica Pharmaceuticals Non-GAAP EPS of -$0.08 beats by $0.06, revenue of $3.44M beats by $0.91M
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - Verrica Pharmaceuticals Inc.
05/12/2025 06:48 PM EDT KlickAnalytics VRCA - Historical Price Movements Surrounding Earnings
05/12/2025 06:43 PM EDT KlickAnalytics VRCA - Historical Earnings Price Analysis
05/12/2025 05:15 PM EDT Zacks Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates
05/08/2025 05:50 PM EDT Zacks 4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.